# Cardiology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Franklin D. Roosevelt (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET002-SYN-TD
- Date: 1944-04-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Miriam Castellanos, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Nathaniel Brooks, MD

## Reason for consultation

New heart failure, probably with reduced ejection fraction and driven by severe hypertension, in a 62-year-old man who smokes and uses a wheelchair. Please review the echocardiogram, confirm the diagnosis and its likely cause, and guide titration of guideline-directed therapy. **S**

## History

Mr. Roosevelt is seen at the request of Dr. Brooks two weeks after presenting with breathlessness, orthopnea, and leg swelling. On sacubitril/valsartan, carvedilol, empagliflozin, and furosemide he is less breathless: he now propels his wheelchair the length of a long corridor before resting and sleeps on two pillows without waking breathless. His home weight has fallen by about 3 kg and his home blood pressures run in the 140s over 80s. He has had no chest pain or pressure at rest or with exertion, no palpitations, no syncope, and no lightheadedness on transfers. He stopped smoking on his quit date last week. His work is demanding and he wants to keep doing it. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert and comfortable at rest in his wheelchair; speaks in full sentences |
| Neck | Jugular venous pressure 9 cm at 45 degrees |
| Lungs | Fine crackles at both bases |
| Heart | Regular rhythm, rate 84; S3; apical impulse displaced laterally |
| Extremities | 1+ symmetric edema at the ankles and shins |

BP 148/88 mmHg; pulse 84 bpm; respirations 18/min; temperature 36.8 °C; oxygen saturation 95% on room air; weight 85 kg; BMI 24 kg/m². All vital signs are synthetic.

## Data reviewed

Today's transthoracic echocardiogram: dilated left ventricle with global hypokinesis and no regional wall motion abnormality, ejection fraction 30 percent, and no significant valve disease. Today's basic metabolic panel, the NT-proBNP, iron studies, lipid panel, HbA1c, and TSH from the referral visit. No ECG from the diagnostic workup is on file. Sodium: 136 mmol/L; Potassium: 4.8 mmol/L; Creatinine: 1.29 mg/dL; eGFR: 63 mL/min/1.73 m²; Glucose: 98 mg/dL; LVEF by echocardiogram: 30% (low). All results are synthetic.

## Assessment

1. **Heart failure with reduced ejection fraction** (I50.22). Confirmed: ejection fraction 30 percent with a dilated, globally hypokinetic left ventricle. He is improving but still mildly congested; NYHA class II to III. Potassium 4.8 mmol/L and creatinine 1.29 mg/dL (eGFR 63) after two weeks of therapy, a rise well within what is accepted, so titration can proceed. **S**
2. **Hypertensive heart disease** (I11.0). Severe hypertension, with a presenting blood pressure of 186/108 mmHg and albuminuria, is the most likely cause. There is no angina and no regional wall motion abnormality, so an ischemic evaluation can wait to see whether the ejection fraction recovers with blood pressure control and therapy. Blood pressure 148/88 mmHg today remains above the 130/80 target. **S**
3. **Iron deficiency in heart failure** (D50.9). Ferritin 48 ng/mL with transferrin saturation 16 percent meets the heart failure criteria for intravenous iron, which improves symptoms and exercise capacity; oral iron does not. **S**

## Recommendations

1. Increase sacubitril/valsartan to 49/51 mg twice daily and carvedilol to 6.25 mg twice daily with food today.
2. Start spironolactone 25 mg daily today; potassium 4.8 mmol/L and eGFR 63 allow it.
3. Continue empagliflozin 10 mg daily, and furosemide 20 mg daily until he is euvolemic.
4. Basic metabolic panel one to two weeks after today's changes.
5. Ferric carboxymaltose 750 mg intravenously today and again in one week.
6. Ischemic evaluation, with pharmacologic stress imaging or coronary CT angiography because he cannot exercise on a treadmill, only if the ejection fraction does not improve on therapy or angina develops.
7. Repeat echocardiogram three to six months after tolerated doses are reached. An implantable defibrillator is indicated only if the ejection fraction is still 35 percent or less after at least three months of therapy; obtain an ECG before that decision to measure the QRS duration.
8. Cardiac rehabilitation once he has had six weeks of therapy, in a program that offers seated arm ergometry and resistance training.
9. Stay off cigarettes; keep alcohol to an occasional drink.

## Strengths and supports

- Supports: spouse, an adult daughter who encouraged this visit, and close staff **S**

## Communication

Discussed with Dr. Brooks in person today; the patient agrees with the plan. **S**

## Follow-up

Primary care will manage the titration and laboratory monitoring on the CMID schedule. Cardiology will see him again for an ejection fraction that stays at 35 percent or less, a failure to improve, new angina or arrhythmia, or a hospital admission. **S**

## Guideline basis

- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022), American Heart Association, American College of Cardiology, and Heart Failure Society of America
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, heart failure and hypertension monographs (2026), Aether Forge
